mTOR Mediated Anti-Cancer Drug Discovery

Drug Discovery Today: Therapeutic Strategies
doi 10.1016/j.ddstr.2009.12.001
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

‘Big Data’ Approaches for Novel Anti-Cancer Drug Discovery

Expert Opinion on Drug Discovery
Drug Discovery
2017English

Po-200 3din Vitrocultures of PDX-Derived Tumour for Anti-Cancer Drug Discovery

2018English

Pharmacogenomics: Activating Cancer Drug Discovery

Environmental Health Perspectives
MutagenesisPublic HealthEnvironmentalHealthToxicologyOccupational Health
2004English

Rapamycin and mTOR: A Serendipitous Discovery and Implications for Breast Cancer

Clinical and Translational Medicine
MedicineMolecular Medicine
2012English

Biomembrane Mimics and Their Roles in Anti-Bacterial Drug Discovery

ADMET and DMPK
PharmacologyHealthMedicineToxicologyChemistryPharmaceutics
2017English

Drug Interaction (27. Anti-Emetics During Anti-Cancer Chemotherapy)

Okayama Igakkai Zasshi (Journal of Okayama Medical Association)
2013English

Anti-Trypanosomatid Drug Discovery: An Ongoing Challenge and a Continuing Need

Nature Reviews Microbiology
Infectious DiseasesImmunologyMicrobiologyMicrobiology
2017English

Drug Discovery

Journal of Antivirals & Antiretrovirals
2010English

Search for Drug Discovery Targets Focusing on Cancer Stroma

Translational and Regulatory Sciences
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy